CGT-19119-96810
5 vaccinations
10 coded responses
58 check-ins
9 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 009 / PR
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
-
2021-01-07
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
-
2021-05-06
Survey response — 3 months, dose 2MedDRA: Photopsia, Vitreous floaters — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Eye floaters and photopsias on April 23, 2021MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-08
Call successfulDoes not wish to fill out VAERS report
- 2021-08-05
-
2021-10-23
Dose 3 — Moderna
- 2021-10-23
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Musculoskeletal disorder — Feeling: Good · Site: PainFree text: Slight limitation of my left arm upward extensionMedDRA releases: 2024-11 · check-in free text available
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-10-30
- 2021-11-07
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2022-01-22
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Office visit, Vertigo positional — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Benign paroxysmal positional vertigo since approximately 1 week ago. · Healthcare visit (other): ENTMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-04-25
Call successfulDoes not wish to fill out VAERS report
-
2022-07-02
Dose 4 — Moderna
-
2022-07-05
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain — Feeling: GoodFree text: Pain at the injection site for almost 24 hours post vaccination and that was it!MedDRA releases: 2024-11 · check-in free text available
- 2022-07-07
- 2022-07-08
- 2022-07-09
-
2022-07-16
Survey response — day 14, dose 4MedDRA: Pain in extremity, Peripheral swelling, Self-medication, Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Acute urticarial rash requiring Rx with Benadryl 50mg PO qhs, Zyxal 5mg PO qam, and after little improvement, started Methylprednisolone 4mg PO, q6hrs, going to my 3rd day on it. No fever. Did have painful hands and feet with slight swelling.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-23
Survey response — day 21, dose 4MedDRA: Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still have the urticarial symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-30
Survey response — day 28, dose 4MedDRA: Arthralgia, Mechanical urticaria, Self-medication, Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent urticarial rashes & dermographism. No further joint pain, no headaches or fever. Still on Xyzal, Benadryl and Pepcid.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-06
Survey response — day 35, dose 4MedDRA: Mechanical urticaria, Urticaria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent urticaria with dermographism since 07/11/22.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-13
-
2022-10-01
Survey response — 3 months, dose 4MedDRA: COVID-19, Cough, Dyspepsia, Dysphonia, Headache, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: COVID-19 between 09/12/22-09/22/22: -hoarseness of voice, sorethroat, headache, heartburn exhacerbationwith dry cough at night -no fever or significant congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Dose 5 — Pfizer-BioNTech
- 2022-12-31
- 2022-12-31
- 2023-01-05
-
2023-01-12
Survey response — day 21, dose 5MedDRA: Skin papilloma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-12
Report sent to call center — day 21, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-13
- 2023-01-19
- 2023-01-19
- 2023-01-28
- 2023-02-02
- 2023-03-23
- 2023-06-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
| 4 | 2022-07-02 | Moderna | No |
| 5 | 2022-12-22 | Pfizer-BioNTech | No |
Call center
4 call center cases
3 successful · 1 unsuccessful
Free text
Release 8 — 3 months, dose 2
Symptoms: Eye floaters and photopsias on April 23, 2021
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Slight limitation of my left arm upward extension
Release 11 — 6 months, dose 3
Symptoms: Benign paroxysmal positional vertigo since approximately 1 week ago.
Healthcare visit (other): ENT
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Pain at the injection site for almost 24 hours post vaccination and that was it!
Release 12 — day 14, dose 4
Symptoms: Acute urticarial rash requiring Rx with Benadryl 50mg PO qhs, Zyxal 5mg PO qam, and after little improvement, started Methylprednisolone 4mg PO, q6hrs, going to my 3rd day on it. No fever. Did have painful hands and feet with slight swelling.
Release 12 — day 21, dose 4
Symptoms: Still have the urticarial symptoms.
Release 12 — day 28, dose 4
Symptoms: Persistent urticarial rashes & dermographism. No further joint pain, no headaches or fever. Still on Xyzal, Benadryl and Pepcid.
Release 12 — day 35, dose 4
Symptoms: Persistent urticaria with dermographism since 07/11/22.
Release 12 — 3 months, dose 4
Symptoms: COVID-19 between 09/12/22-09/22/22: -hoarseness of voice, sorethroat, headache, heartburn exhacerbationwith dry cough at night -no fever or significant congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspepsia | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Mechanical urticaria | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Photopsia | ✓ | ✓ | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Skin papilloma | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
| SD | Vitreous floaters | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Musculoskeletal disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release